February 8, 20240 citationsOpen Access

Table S1 from Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti–PD-1 Monotherapy: A Report from the International RRD Consortium

Key points are not available for this paper at this time.

Baseline characteristics of patients with RRD high-grade gliomas treated with immune-checkpoint inhibition (ICI) (n=75)

问 AI

Bookmark

View Full Paper

问 AI

Bookmark

View Full Paper

Cite This Study